Investor Relations

Orexo's share is listed on NasdaqOMX Stockholm, Sweden (ORX), and is available as American Depository Receipts on OTCQX market in the US (OXROY).

Share price

Name
0.00
0 SEK (0%)
HH:MM CET • 20YY-MM-DD

Latest CEO Comments

APRIL 29, 2021

"ZUBSOLV® demand will contribute to a solid foundation for future growth"

Read the latest CEO comments from Nikolaj Sørensen

Key financial figures

Group net revenue

621 MSEK
Last Twelve Months, Q220-Q121

Group EBITDA

-44 MSEK
Last Twelve Months, Q220-Q121

US Pharma segment EBIT

322 MSEK
Last Twelve Months, Q220-Q121

Cash position

726 MSEK
Q121
IR-Contact